← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2007Last known activity
May 25, 2018
Defunct as of Mar 15, 2022
Timeline
1990s
- Dec 1, 1994
Quark Pharmaceuticals— Founded
2020s
- Mar 15, 2022
Quark Pharmaceuticals— Defunct
Drugs by trial phase (6 distinct, 13 trials)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Atrophy
- Choroidal Neovascularization
- Delayed Graft Function
- Diabetes Complications
- Diabetic Retinopathy
- Edema
- Glaucoma
- Glaucoma, Angle-Closure
- Ischemia
- Macular Degeneration
- Macular Edema
- Neovascularization, Pathologic
- Optic Atrophy
- Optic Nerve Diseases
- Optic Neuropathy, Ischemic
- Renal Insufficiency
- Wounds and Injuries
Recent trials (23)
- NCT03510897Lead sponsorPhase 3May 25, 2018
- NCT03510897Study directorPhase 3May 25, 2018
- NCT02610296Study directorPhase 3Dec 1, 2015
- NCT02610283Lead sponsorPhase 2Dec 1, 2015
- NCT02610296Lead sponsorPhase 3Dec 1, 2015
- NCT02610283Study directorPhase 2Dec 1, 2015
- NCT02341560Study directorPhase 2/Phase 3Oct 1, 2015
- NCT02341560Lead sponsorPhase 2/Phase 3Oct 1, 2015
- NCT01965106Study chairPhase 2Dec 1, 2013
- NCT01965106Lead sponsorPhase 2Dec 1, 2013
- NCT01445899Study directorPhase 2Feb 1, 2012
- NCT01445899Lead sponsorPhase 2Feb 1, 2012
- NCT01064505Study directorPhase 1Feb 1, 2010
- NCT01064505Lead sponsorPhase 1Feb 1, 2010
- NCT00713518Lead sponsorPhase 2Nov 1, 2009
Details
- Founded
- Fremont, CA, US Dec 1, 1994
- Last known activity
- May 25, 2018